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Abstract
Tenomodulin (Tnmd) is a type II transmembrane protein characteristically expressed in dense connective tissues such as
tendons and ligaments. Its expression in the periodontal ligament (PDL) has also been demonstrated, though the timing
and function remain unclear. We investigated the expression of Tnmd during murine tooth eruption and explored its
biological functions in vitro. Tnmd expression was related to the time of eruption when occlusal force was transferred to the
teeth and surrounding tissues. Tnmd overexpression enhanced cell adhesion in NIH3T3 and human PDL cells. In addition,
Tnmd-knockout fibroblasts showed decreased cell adhesion. In the extracellular portions of Tnmd, the BRICHOS domain or
CS region was found to be responsible for Tnmd-mediated enhancement of cell adhesion. These results suggest that Tnmd
acts on the maturation or maintenance of the PDL by positively regulating cell adhesion via its BRICHOS domain.
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Introduction
The periodontal ligament (PDL) is a supporting tissue that plays
important roles in connecting teeth to the jaw, sensing occlusal
force, and providing shock absorption [1]. Periodontitis is one of
the world’s most common infectious diseases, affecting approxi-
mately 40% of adults aged 35–44 [2]. Microorganisms in the oral
cavity and an aggressive response of the immune system against
them cause this inflammatory disease [3], ultimately resulting in
loss of the functions of the PDL and involved teeth. In addition,
recent studies have reported a close relation between severe
periodontitis and the progression of diseases such as type 2
diabetes mellitus [4], rheumatoid arthritis [5], hypertension [6,7],
and atherosclerosis [8,9], indicating the importance of oral
healthcare. Once the PDL is destroyed, regeneration is challeng-
ing; reliable treatment to fully recover the PDL is limited due to
the shortage of knowledge about how the PDL is developed and
maintained during and after tooth eruption. Therefore, un-
derstanding the nature of the PDL in order to establish an
effective and practical regeneration strategy is an important task
for both medical and dental health care.
Tnmd is a type II transmembrane protein [10], and it has been
reported to characteristically express in dense connective tissues
such as tendons and ligaments [11,12]. The structure of Tnmd
includes a highly conserved C-terminal domain (CTD), putative
enzyme cleavage site (CS), BRICHOS domain that has two
glycosylation sites, transmembrane region, and cytoplasmic tail
[10,13,14]. The CTD contains eight cysteine residues that form
four disulfide bonds, which are also conserved in chondromodulin-
1 (ChM-1). The CS contains the R-X-R/L-R basic target
sequence for furin, an endoprotease enriched in the Golgi
apparatus that functions as a proprotein convertase
[11,12,15,16]. The BRICHOS domain contains two conserved
cysteines that are presumed to form disulfide bonds and two N-
glycosylation sites. The framework of this domain has been
suggested to be similar to that of the GroEL apical domain, which
is the polypeptide recognition domain [17]. Suggested functions of
this domain, including targeting of the secretory pathway, may
assist the specialized intracellular protease processing system and
provide an intramolecular chaperone-like function, although its
role in cellular function is unclear [14].
Tnmd expression has been confirmed with RT-PCR and in situ
hybridization of brain, heart, tendon, ligament, sclera, and cornea
[11,12,18,19,20]. As for its biological function, the CTD of Tnmd
has been shown to have the anti-angiogenic effect, when
overexpressed in endothelial cells [21]. Given that Tnmd is
known to emerge in the late developmental stage of tendons and
ligaments [19] and the PDL is categorized as a dense connective
tissue, it is possible that Tnmd has roles in the development and
maintenance of the PDL and serves as a biomarker characterizing
functions of it. However, there has been no report on the
expression pattern or biological function of Tnmd in periodontal
tissues.
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In the present study, we aimed to understand the biological
roles of Tnmd in the PDL. We established rabbit polyclonal anti-
Tnmd antibodies and investigated the pattern and timing of Tnmd
expression in the PDL of wild type (WT) mice in comparison with
those of Tnmd-knockout (Tnmd-KO) mice. We further examined
the cellular functions of Tnmd in NIH3T3 cells and human
immortalized PDL cells as well as its subcellular localization.
Materials and Methods
Cells, Plasmid Vectors, and Mice
NIH3T3 cells were obtained from RIKEN Cell Bank. Human
immortalized PDL cells (hPDL-TERT) were established as de-
scribed previously [22]. Cells were cultured in Dulbecco’s
modified Eagle medium (DMEM) containing 10% fetal bovine
serum (FBS) at 37uC under 5% CO2 in air. pCAGGS-FLAG-
mTnmd was generated by polymerase chain reaction (PCR) using
pCAGGS as described previously [10]. A bicistronic expression
vector with Venus and FLAG-Tnmd was generated using PCR.
Tnmd-KO mice were generated as described previously [23].
Littermates were mated to generate Tnmd heterozygotes or
hemizygotes. Genotypes and sex were identified using PCR with
the following primers: Tnmd WT, F:aactccacctcagcagtactcc;
Tnmd KO, F:gattagataaatgcctgctc; Tnmd WT/KO, R:ttcttgga-
tacctcgggccag; mSry, F:ctcatcggagggctaaagtg; and mSry,
R:aagctttgctggtttttgga. All animal experiments were approved by
the animal welfare committee of Tokyo University Graduate
School of Medicine.
Establishment of Anti-Tnmd Specific Antibody
A polyclonal antibody to mouse Tnmd was raised by
immunizing rabbits with a polypeptide corresponding to the
region with amino acids LHFPTSEKKGIDQNE (Figure 1).
Immunization was performed every week for 5 weeks and the
obtained serum was titered on week 6. When a sufficient antibody
titer was confirmed, the antigen was administered again as
a booster. Whole serum samples were collected on week 7 and
ProClin (Sigma-Aldrich) was added to preserve the samples until
affinity purification at 280uC. For purification, antisera were
precipitated with 45% ammonium sulfate and centrifuged. The
pellet was dissolved in phosphate buffered saline (PBS) and
desalted using a PD-10 column (GE Healthcare), and then the
protein solution was loaded onto an affinity column overnight at
4uC on a rotator. The column was then washed with PBS and the
antibody eluted using 3 M MgCl. The protein concentration of
each fraction was measured using a spectrophotometer (Nano-
drop-1000; Thermo Scientific), then collected and desalted again,
and buffered with PBS. The antibody solution was concentrated
by ultrafiltration (Millipore, Bedford, MA), and equal volumes of
glycerol and 15 mM NaN3 were added to be stored at 230uC
until use in the experiments.
Cleavage of N-glycans and Inhibition of Glycosylation in
vitro
NIT3T3 cells were seeded at 4.06104 cells/dish and cultured
for 10–12 hours. At 48 hours after transfection, cells were collected
in 1% SDS and sonicated for 3 minutes on ice. The lysates were
centrifuged at 15,000 rpm for 20 minutes at 4uC, and then the
supernatants were treated with PNGaseF (Sigma Aldrich, St.
Louis, MO) for various amounts of time. Tunicamycin (Sigma-
Aldrich) was used to inhibit glycosylation. NIT3T3 cells were
seeded at 4.06104 cells/dish and cultured for 10–12 hours. At 24
hours after transfection, 0.5 or 1.0 mg/ml of tunicamycin was
added. The cells were harvested at 48 hours after transfection and
subjected to western blot analysis.
Cell Fractionation, Gels, Coomassie Brilliant Blue (CBB)
Staining, and Western Blot Analysis
To obtain the intracellular fraction, a ProteoExtract Subcellular
Extraction kit (Calbiochem, La Jolla, CA) was used according to
the manufacturer’s instructions. Each fraction was denatured by
boiling in sample buffer containing 50 mM DTT for 5 minutes
and subjected to SDS-PAGE. For whole cell analysis, cultured
cells were washed with PBS twice and fixed with 10%
trichloroacetic acid (TCA) on ice for 20 minutes. After fixation,
cells were collected in micro-centrifugation tubes and washed
twice with PBS. The pellets were eluted in buffer containing 2 M
Urea, 7 M Urea, 3% CHAPS, and 1% TritonX-100. Cell lysates
were collected by centrifugation at 15,000 rpm for 30 minutes at
4uC, then mixed with 4x SDS sample buffer. Samples were
electrophoresed on 10–20% SDS-polyacrylamide gels. For CBB
staining, the gel was stained with 50 ml of Bio-safe CBB G-250
(Bio-rad Laboratories Inc., Hercules, CA) for 1 hour and washed
overnight with distilled water. The gels were then imaged with
a digital photoscanner GT-X700 (Seiko Epson Corp., Nagano,
Japan). For western blot analyses, gels were transferred onto
Immobilon-P membranes (Millipore, Bedford, MA). After pre-
incubation with blocking buffer (1% bovine serum albumin, 0.1%
Tween 20, in TBS), the membranes were incubated with either
a rabbit anti-Tnmd polyclonal antibody against the synthetic
peptide corresponding to the human/mouse Tnmd sequence from
Thr124 to Glu136 or anti-FLAG polyclonal antibody (Sigma
Aldrich), followed by incubation with horseradish peroxidase
(HRP)-conjugated anti-rabbit or anti-mouse IgG antibodies
(Promega, Madison, WI). Peroxidase activity was visualized using
an enhanced chemiluminescence (ECL) plus system (Amersham
Pharmacia Biotech Inc., Buckinghamshire, UK), according to the
manufacturer’s instructions.
Immunocytochemistry
NIH3T3 cells were seeded on cover glasses and cultured for 10–
12 hours. For transfection, 0.2 synthetic peptide corresponding to
the human/mouse Tnmd sequence from Thr124 to Glu136 or
anti- washed twice with PBS and fixed with 1% glutaraldehyde
supplemented with MgCl2 and saponin for 20 minutes. Each
specimen was washed twice with PBS and blocked with Tris-
buffered saline containing 1% bovine serum albumin and 0.05%
Tween-20 (BSA/TBS-T) for 1 hour at room temperature, then
incubated with the following primary antibodies overnight at 4uC:
anti-pan-cadherin antibody (anti-PC antibody) at 1:200, wheat
Figure 1. Illustration of Tnmd structure and design of antibody
recognition position. Schematic illustration of the Tnmd structure.
Domain structures are highlighted. The position of the antibody
recognition site is indicated in red. The N-glycan glycosylation site is
indicated by a hexangular box with the amino acid number. Conserved
cysteine residues are indicated in capital letters. Transmembrane:
transmembrane region; BRICHOS: BRICHOS domain; CS: possible
cleavage site; CTD: C-terminal domain.
doi:10.1371/journal.pone.0060203.g001
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Figure 2. Expression of Tnmd in the mouse periodontal ligament. (A) Immunohistochemical detection of Tnmd in the incisors. Tnmd
localization was examined by IHC in mandible incisors obtained from 4-week-old mice. (B) Immunohistochemical detection of Tnmd in molars. The
temporal expression of Tnmd was examined by IHC in maxilla molars obtained from 2, 3, and 4-week-old mice. e: enamel organ; d: dentin; g: gingiva;
pul: pulp; pdl: periodontal ligament; b: bone. The dotted line indicates the area of periodontal ligament. Arrow indicates the region of positive signal.
Scale bar = 500 mm.
doi:10.1371/journal.pone.0060203.g002
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Figure 3. Determination of the subcellular localization of Tnmd. (A) Detection of Tnmd in cell fractions by western blotting. (B) Examination
of the glycosylation of Tnmd with tunicamycin treatment. (C) Examination of the N-glycosylation of Tnmd with PNGase treatment. WL, whole cell
lysate; Cytl: cytosol fraction; Mem: membrane fraction; Nuc: nuclear fraction; Cytn: cytoskeleton fraction. (D-G) The subcellular localization of the
Tnmd protein in NIH3T3 cells transfected with Tnmd was examined by ICC. NIH3T3 cells were stained with cell organelle markers to indicate the
plasma membrane [upper panels]. NIH3T3 cells transfected with Tnmd were double stained with cell organelle markers and the anti-Tnmd antibody
Tnmd Expression in PDL Enhances Cell Adhesion
PLOS ONE | www.plosone.org 4 April 2013 | Volume 8 | Issue 4 | e60203
germ agglutinin Tetramethylrhodamine conjugate (WGA) at
1:1000, anti-beta actin antibody at 1:400, anti-alpha tubulin
antibody at 1:400, and anti-Tnmd antibody at 1:400. The
specimens were then incubated with the following secondary
antibodies for 1 hour at room temperature: anti-mouse IgG
antibody Alexafluor 546 conjugate at 1:1000, and anti-rabbit IgG
antibody Alexafluor 546 or 647 conjugate at 1:1000. The
specimens were enclosed with Aquatex (Merck KGaA, Darmstadt,
Germany) and stored at 4uC away from light until observations
were performed with a confocal laser scan microscope LSM510
(Carl Zeiss Microscopy Co., Ltd., Tokyo, Japan). Obtained digital
images were processed using Adobe PhotoshopH software (Adobe
Systems Inc., Tokyo, Japan).
Histological Analysis
1, 2, 3, 4, 6, or 10-week-old mice were euthanized with
isoflurane inhalation. Before fixation, 30 mM HEPES was
perfused to wash out blood, and then 10% neutral buffered
formalin was used for perfusion fixation and the tissue of interest
was isolated. Tissues were further fixed overnight at 4uC and
decalcification was performed with 20% EDTA (pH 7.4) at 4uC
for 7–10 days, with the solution changed every day. The tissues
were then washed with water and embedded in paraffin.
Sectioning was done using a standard technique to produce 4-
mm thick sections that were utilized for further analysis. The
specimens underwent Hematoxylin and eosin (H&E) staining
according to a standard protocol. Images were taken by an Axio
imager.A1 microscope (Zeiss) as described below utilizing a x2.5
apochromatic objective lens. Digital images were captured by
Axiocam MRc and Axiovision ver. 4.6 (Zeiss) and processed using
Adobe PhotoshopH software (Adobe Systems Inc.). The 10-week-
old mouse specimens were subjected to microfocus X-ray CT
analysis by using an inspeXio SMX-90CT (Shimadzu Corpora-
tion, Kyoto, Japan) according to the manufacturer’s instructions.
Immunohistochemistry
The specimens were deparaffinized and immersed in water,
followed by an antigen retrieval procedure with a 0.05% Trypsin-
EDTA solution for 15 minutes at room temperature. Each
specimen was neutralized in TBS and blocked with 1% BSA/
TBS-T for 1 hour, and then endogenous peroxidase was
inactivated using 0.3% H2O2. Anti-Tnmd antibody was used as
the primary antibody at 1:400 and cultured overnight at 4uC. For
the secondary antibody, MAX-PO rabbit IgG (Nichirei, Tokyo,
Japan) was added for 1 hour at room temperature. Each specimen
was washed with TBS-T and visualized with AEC (Nichirei), then
counterstained with hematoxylin. Enclosed specimens were
observed under a light field microscope, Axio imager.A1 (Zeiss),
utilizing a x2.5, x5, or x10 apochromatic objective lens. Digital
images captured by Axiocam MRc and Axiovision ver.4.6 (Zeiss)
were processed using Adobe PhotoshopH software (Adobe Systems
Inc.).
Cell Adhesion Assay
Ninety-six-well microtiter plates were coated with 1% BSA,
a type I collagen (Col I) solution and incubated overnight at 4uC.
To prevent the cells from directly attaching to the microtiter
plates, 1% BSA was used. The coated plates were dried at room
temperature and washed twice with sterile PBS, and then cells
transfected with expression vectors were seeded on the plates.
After 1 hour or 30 minutes of incubation for NIH3T3 or hPDL-
TERT cells, respectively, the input fluorescence of each well was
detected using a Typhoon confocal laser scanner (GE Healthcare,
Buckinghamshire, UK) or InCell analyzer 1000 (GE Healthcare).
The plates were then washed with PBS 3 times and the
fluorescence of each well was detected again as the adherent cell
fluorescence. The entire fluorescence value for each well in terms
of cell numbers was measured using the Typhoon scanner and the
adherent cell ratio was calculated.
[lower panels]. (D) Tnmd and plasma membrane marker, Pan-Cadherin (Cad). (E) Tnmd and Golgi apparatus marker, Wheat germ agglutinin (WGA).
(F) Tnmd and b-Actin (Act). (G) Tnmd and a-Tubulin (Tub). SYTOX nuclear staining is shown in blue, cell organelle markers in green, and anti-Tnmd
antibody in red. White arrowhead indicates the positive staining or organelle markers or anti-Tnmd antibody. Yellow arrowhead indicates the
colocalization of the organelle marker signal and Tnmd signal. Scale bar = 50 mm.
doi:10.1371/journal.pone.0060203.g003
Figure 4. Morphological changes of Tnmd-transfected NIH3T3
cells. (A) Immunocytochemical detection of Tnmd in NIH3T3 cells
transfected with Tnmd or GFP. DAPI: nuclear staining. Scale bar = 50 mm.
(B) Measurement of the cell area and perimeter of NIH3T3 cells
transfected with Tnmd or GFP. Cells in 5 microscopic fields were
measured. Tnmd group: n = 16; GFP group: n = 13. White spot: average
value.
doi:10.1371/journal.pone.0060203.g004
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Figure 5. Effect of Tnmd transfection on cell adhesion of fibroblastic cells. (A) Dose-dependent enhancement of cell adhesion by Tnmd.
FLAG-tagged Tnmd was transfected in combination with pCAGGS-Venus in NIH3T3 cells. Cell adhesion to col I-coated culture dishes was determined.
The fluorescence intensity was measured using a confocal laser scanner, and the percent cell adhesion was calculated. (B) Relative expression levels
of Tnmd mRNA in WT and Tnmd-KO cells determined by real-time RT-PCR. (C) Cell adhesion of WT and Tnmd-KO cells to col I-coated culture dishes.
(D) Illustration of the domain deletion mutants of Tnmd. Tnmd FC: FLAG-tagged full length Tnmd; Tnmd DCTD (DCTD): C-terminal domain deletion
mutant; Tnmd DCS (DCS): mutant with a deleted putative cleavage site; Tnmd DBRICHOS (DBRI): BRICHOS domain deletion mutant; Tnmd DEC (DEC):
mutant with the entire extracellular portion of the molecule deleted. (E) Expression of Tnmd mutants. Expressions of Tnmd mutants were analyzed by
western blotting using the anti-FLAG antibody. Each mutant was transfected into NIH3T3 cells. (F) Effect of FLAG-tagged Tnmd or domain deletion
mutants on cell adhesion in NIH3T3 cells. NIH3T3 cells were transfected with beta galactosidase [control], FLAG-Tnmd, DCTD, DCS, DBRI, or DEC in
combination with pCAGGS Venus. Cell adhesion to col I-coated culture dishes was determined. The percent cell adhesion was calculated based on
the fluorescence intensity measured by a confocal laser scanner. Three measurements were performed for each and representative values are shown
as the means6SD. *p,0.05; ns: not significant.
doi:10.1371/journal.pone.0060203.g005
Tnmd Expression in PDL Enhances Cell Adhesion
PLOS ONE | www.plosone.org 6 April 2013 | Volume 8 | Issue 4 | e60203
RNA Isolation, Reverse Transcription, and Quantitative
Polymerase Chain Reaction (qPCR)
Total RNA was isolated using an ISOGEN kit (Wako Pure
Chemical Industries, Ltd., Tokyo, Japan) and treated with DNase
1 (Qiagen, Hilden, Germany), following the manufacturer’s
instructions. After reverse-transcription using a QuantiTectH Re-
verse Transcription Kit (Qiagen), PCR was performed with an
ABI Prism 7000 Sequence Detection System (Applied Biosystems,
Foster City, CA) using QuantiTect SYBR Green PCR Master Mix
(Qiagen). All reactions were run in triplicate. The mRNA copy
number of a specific gene was calculated with a standard curve
generated using serially diluted plasmids containing PCR
amplicon sequences, and normalized to human or rodent total
RNA with mouse actin used as the internal control. Standard
plasmids were synthesized using a TOPO TA cloning Kit
(Invitrogen, Carlsbad, CA), according to the manufacturer’s
instructions. Data are expressed as the means6SD. The primer
sequences are available upon request.
Statistical Analysis
The significance of differences was determined with Student’s t-
test in the results of cell adhesion assay. The mean values of groups
were compared using ANOVA and the significance of differences
was determined with Tukey’s post hoc test in the results of cell
adhesion assay for deletion mutants.
Results
Establishment of Anti-Tnmd Antibody
To explore the expression pattern of Tnmd in mouse PDLs, we
established a polyclonal antibody against an amino acid sequence
of the N-terminal side of the CS region of mouse Tnmd (Figure 1).
In western blot analysis of NIH3T3 cells transfected with Tnmd
(Tnmd-overexpressing NIH3T3 cells), the anti-Tnmd antibody
detected 45-and 40-kDa bands (Figure S1A), which was in
agreement with previous reports [10,15,20,24]. Anti-Tnmd
antibody did not recognize any proteins in NIH3T3 cells
transfected with or without the unrelated GFP gene. We also
examined FLAG-tagged Tnmd (FL-Tnmd) using an anti-FLAG
antibody to compare with the results obtained with the anti-Tnmd
antibody. In NIH 3T3 cells transfected with FLAG tagged-Tnmd
(FL-Tnmd-overexpressing NIH3T3 cells), the anti-FLAG antibody
detected 45- and 40-kDa bands, which were the same as those
detected with anti-Tnmd antibody on the same membrane (Figure
S1B). To further examine the specificity of the anti-Tnmd
antibody, immunohistochemistry (IHC) was performed with tail
tissues of Tnmd-KO and WT mice (Figure S1C). Normal rabbit
serum was used as a negative control, and did not detect any signal
in either strain of mice. Anti-Tnmd antibody detected a specific
signal in tenocytes of the WT mice, with higher staining intensity
in the insertion of tendon, while no signal was detected in the
Tnmd-KO mice (Figure S1C). Taken together, these results showed
that the anti-Tnmd antibody was able to specifically detect Tnmd
in both western blot analysis and IHC.
Analysis of Tnmd Expression in the PDL
Murine incisors continue to erupt throughout life, while murine
molars stop erupting with the formation of an apex of the root at
some point in life. Hence, it is considered that the morphology,
mechanism of root formation, and pattern of eruption in murine
molars were similar to those in humans. H&E staining of 1, 2, 3, 4,
and 6-week-old WT mouse molars revealed that their eruption
was likely to occur between the ages of 2 and 3 weeks (Figure S2).
Two-week-old mouse molars were still covered by oral mucosa. In
contrast, the crown tip had already penetrated the oral mucosa in
3-week-old mice (Figure S2). Attrition of the crown tip was
observed in 4-week-old mice, suggesting that the molars had
started to function. Taken together, these results showed that
molars in the 2, 3, and 4-week-old mice were likely in the
preeruptive, eruptive, and posteruptive phase, respectively.
Therefore, we performed IHC of Tnmd to investigate expression
in 4-week-old mice incisors and molar PDLs, i.e., in the
posteruptive phase. IHC without the primary antibody or with
normal rabbit serum served as a negative control, which did not
detect positive signals from any of the tested specimens. In
contrast, IHC of Tnmd revealed positive signals in PDL cells,
odontoblasts, and periosteum cells in 4-week-old WT mouse
incisor and molar specimens, while those in Tnmd-KO mice did
not have such signals (Figure 2A and B). Positive signals were also
observed in 3-week-old WT mouse molars. Such signals were
barely observed in 2-week-old WT mouse molars (Figure 2B).
Although Tnmd expression in the PDL was detected in the
eruptive and posteruptive phases, the molar eruption in Tnmd-KO
mice was not delayed.
To explore the function of Tnmd in the PDL, craniocervical
hard tissues from WT and Tnmd-KO mice were analyzed using
a microfocus X-ray CT system. There were no gross abnormalities
in tooth number, number of tooth roots, or morphology of the
craniocervical hard tissues, including the teeth, cranial bones,
facial bones, and jaw bones (Figure S3). Thus, Tnmd does not
affect hard tissue development in the oral and craniofacial regions.
Subcellular Localization of Tnmd
The subcellular localization of Tnmd was investigated in Tnmd-
overexpressing NIH3T3 cells by western blot analysis of fraction-
ated lysates. Each fraction showed unique band patterns in CBB
staining of SDS-PAGE gels, which supported the integrity of cell
fractionation (data not shown). In western blot analysis, anti-Tnmd
antibody detected 45- and 40-kDa protein signals in the whole cell
lysates and membrane fractions, and a 45-kDa protein signal in
the cytoskeleton fraction (Figure 3A, Figure S4). Since the two
different signals of Tnmd have been reported to cause by N-
glycosylation [15], we examined the N-glycosylation of Tnmd by
adding tunicamycin, an inhibitor of glycosylation, to the culture
(Figure 3B) and by digesting the cell lysates with PNGaseF
Figure 6. Effect of Tnmd transfection on cell adhesion of PDL-
hTERT cells. (A) Expression of Tnmd in PDL-hTERT cells transfected
with a bicistronic vector carrying FLAG-tagged Tnmd or LacZ and Venus
[pEBMulti-FLAG-Tnmd-2a-Venus, pEBMulti-LacZ-2a-Venus], as deter-
mined by western blotting. FLAG-tagged Tnmd was detected by anti-
FLAG antibody, and Venus was detected by anti-GFP antibody. (B)
Effect of Tnmd on cell adhesion of PDL-hTERT cells to col I-coated
culture dishes. The fluorescence intensity was measured using
a confocal laser scanner and the percent cell adhesion was calculated.
doi:10.1371/journal.pone.0060203.g006
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(Figure 3C). Cells treated with 0.5 mg/ml tunicamycin showed
signals for a 45, 42.5, and 40-kDa protein, and those treated with
1.0 mg/ml tunicamycin showed a signal for a 40-kDa protein.
Treatment of cell lysates with PNGaseF also eliminated the 45-
kDa protein. Thus, we considered that the 45-kDa protein was
likely glycosylated Tnmd and the 40-kDa protein was likely non-
glycosylated Tnmd.
We next performed immunocytochemistry (ICC) of Tnmd-
overexpressing NIH3T3 cells. Tnmd was colocalized with the cell
membrane marker Pan-cadherin (Figure 3D) as well as the Golgi
apparatus marker WGA (Figure 3E). When co-stained with the
cytoskeleton markers, Tnmd was colocalized with actin (Figure 3F).
Tubulin also tended to be colocalized with Tnmd (Figure 3G),
though Tnmd staining was richer in the membrane. Thus, the
protein was localized in the Golgi apparatus, cytoskeleton, and cell
membrane.
Morphological Analysis of Tnmd-transfected NIH3T3 Cells
Since Tnmd-overexpressing NIH3T3 cells tended to have longer
cell processes than NIH3T3 cells transfected with GFP, as shown
by microscopic observations (Figure 4A), we compared the
morphology of Tnmd-overexpressing NIH3T3 cells with that of
GFP-overexpressing NIH3T3 cells by measuring the area and cell
perimeter (Figure 4B). Both parameters were significantly in-
creased in Tnmd-overexpressing NIH3T3 cells as compared to
GFP-overexpressing NIH3T3 cells (743.36607.7 mm2 vs.
207.6659.0 mm2, p= 0.005; 207.16151.6 mm vs.
115.8631.0 mm, p= 0.049). These results indicate that Tnmd
may influence cell morphology.
Effect of FLAG-tagged Tnmd Transfection on Adhesion
Given that Tnmd-overexpressing NIH3T3 cells showed mor-
phological change, we hypothesized that cell adhesion was altered
by the introduction of Tnmd. To investigate the effect of Tnmd on
cell adhesion, we performed a cell adhesion assay, in which cells
co-transfected with Tnmd and the marker gene were grown on Col
I or Fibronectin (FN)-coated culture plates, followed by washout of
unattached cells to detect adherent ones. Col I and FN were used
for the adhesion assay because it is the major extracellular matrix
protein in the PDL. The adhesion ratio of Tnmd-transfected cells
was significantly increased as compared to that of the beta-
galactosidase (LacZ)-transfected controls both to Col I and FN
(Figure 5A, Figure S5A), in a transgene-dose dependent manner
(p = 0.00013 and p=0.00024, respectively). This result suggests
that Tnmd participates in cell adhesion. The effect of Tnmd on
cell adhesion was confirmed using cells isolated from neonatal
connective tissues of WT and Tnmd-KO mice. The expression of
Tnmd was confirmed by quantitative RT-PCR (Figure 5B). Tnmd-
KO cells showed decreased adhesion to both Col I and FN as
compared to WT cells (Figure 5C, Figure S5B). To determine
which domain was responsible for the effect of Tnmd on cell
adhesion, we tested its domain deletion mutants (Figure 5D). The
integrity of the WT and mutants was supported by the following
two observations. First, each type of mutant showed cellular
protein expression comparable to that of the WT (Figure 5E).
Second, the transfection efficiency did not differ among them (data
not shown). FLAG-Tnmd-overexpressing NIH3T3 cells and
DCTD-overexpressing NIH3T3 cells showed markedly greater
adherence to Col I-coated plates compared to the control cells. In
contrast, DCS-, DBRICHOS-, and DEC-transfected NIH3T3 cells
did not enhance the adherence (Figure 5F). Taken together, these
results showed that the CS region and BRICHOS domain in
Tnmd may have an important role in cell adhesion to the
extracellular matrix.
We also investigated the effect of Tnmd on the adhesion of
hPDL-TERT cells that were established from human PDL. To
observe the adhered cells more accurately, we constructed
a bicistronic expression vector expressing both the FLAG-tagged
Tnmd and Venus, an enhanced yellow fluorescent protein, using a 2a
peptide sequence. The protein expression and cleavage by the 2a
peptide sequence were confirmed on western blot analysis
(Figure 6A). FLAG-tagged Tnmd and Venus were detected as their
estimated molecular weight, suggesting that the protein was
cleaved by the 2a peptide sequence. hPDL-TERT cells transfected
with the Tnmd showed enhanced cell adhesion (Figure 6B). As seen
in NIH3T3 cells, Tnmd was localized in the Golgi apparatus,
cytoskeleton, and cell membrane in the PDL-hTERT cells (Figure
S6). These results suggest that Tnmd participates in the adhesion
of PDL cells to the extracellular matrix.
Discussion
This study had five major findings. 1) Tnmd was modified by
two N-glycans, and its CTD was not cleaved in NIH3T3. 2) The
Tnmd protein was expressed in the PDL during the eruptive phase
in murine molars. 3) Tnmd was localized in the plasma
membrane, and transfection of Tnmd enlarged the cell territory.
4) Transfection of Tnmd enhanced cell adhesion, while loss of Tnmd
suppressed it. 5) The BRICHOS domain and the CS region were
important for the enhancement. Based on these findings, we
propose that Tnmd is expressed after the tooth erupts to the oral
cavity, and is involved in maturation and maintenance of the
structure of the PDL by positively regulating adhesion of PDL cells
to ECM.
In western blot analysis, Tnmd was detected as two protein
bands in NIH3T3 cells. We investigated whether or not this
difference of molecular weight was caused by CTD cleavage or by
post-transcriptional modification. We found a change in molecular
size from 45 to 40 kDa upon PNGase F treatment of whole cell
lysates, which is consistent with a previous report [15]. The
cleaved Tnmd is supposed to form two fragments, the larger one
including the transmembrane region and BRICHOS domain, and
the shorter one corresponding to CTD [24]; the CTD was
detected in the tendon [23] and tendious cord of the heart [24] as
an approximately 16-kDa protein. If the CTD is released from
Tnmd, the antibody utilized in our study should detect the rest of
the protein as approximately 29-kDa protein. However, we did not
detect the 29-kDa protein. Although this discrepancy might reflect
the difference between the in vivo and in vitro setting, these data
suggest that the 45 and 40 kDa molecular size of Tnmd was
caused by N-glycosylation, not by protein cleavage. As previously
noted by others, Tnmd has two N-glycosylation sequences. The
appearance of 3 bands by the addition of 0.5 mg/ml tunicamycin
also indicates that both N-glycosylation sites were biologically
modified. Glycosylation of protein may play multiple roles, such as
modification and maintenance of protein folding, which could
directly modulate the function of the protein [25]. Given that the
BRICHOS domain was found to be important for the function of
Tnmd in this study, N-glycosylation to the BRICHOS domain
might be important for the function of Tnmd.
We found that Tnmd expression in the PDL was related to
tooth eruption, which occurred at the time when the dental follicle
developed into the PDL. The specificity of our anti-Tnmd
antibody was investigated on murine tail tendon. The anti-Tnmd
antibody detected signals in tendon [11,12,26]. We examined the
Tnmd expression in the PDL using 2- to 4-week-old mice, in
which eruption of the molar teeth occurred, for the following two
reasons. First, Tnmd expression is known to increase at the later
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stage of development of dense connective tissues such as the limb
tendon [19]. Second, the PDL began to form shortly after root
formation, which occurs at around 2 weeks of age [27]; this age
was considered to be at the earlier stage of dense connective tissue
formation. In the expression analysis, we attempted to associate
Tnmd expression with the three phases of tooth eruption described
by Nanci et al. [28]: Tnmd emerged in the PDL at the eruptive
phase; its expression became more obvious at the eruptive phase;
and its expression was persistent even at the posteruptive phase. In
addition, the increase of Tnmd expression in the PDL also
appeared to be synchronized with dental attrition, a sign that the
occlusal force had been received. These results suggest that the
Tnmd expression is linked to the time when the murine teeth
began to function.
The localization of Tnmd in the plasma membrane suggests
that its function is related to cell adhesion and the control of cell
morphology. By cell fractionation, glycosylated and non-glycosy-
lated form of Tnmd was detected in the membrane fraction.
Glycosylated Tnmd was detected in the cytoskeletal fraction on
western blot. In ICC, Tnmd was colocalized in the Golgi
apparatus, microtubules, and plasma membrane. These results
suggest that Tnmd that is modified in the Golgi apparatus is
transported to the plasma membrane through the intracellular
traffic system. Moreover, Tnmd is expressed in odontoblast,
a unique cell population that aligns as a single layer between the
dentin and pulp and forms dentin throughout life [28]. These cells
contribute to the dentin-pulp complex via their cellular processes
remaining in formed dentin [29]. The Tnmd expression in
odontoblasts may support our findings on the Tnmd-mediated
extension of cellular processes.
Our findings on cell adhesion suggest that Tnmd may play a role
in cell adhesion to the extracellular matrix. Gain of function of
Tnmd enhanced cell adhesion to col I, while loss of Tnmd
decreased cell adhesion. Moreover, transfection of Tnmd to
hPDL-TERT enhanced its adhesion. Despite the enhanced cell
adhesion by Tnmd as well as the expression of Tnmd in the PDL,
Tnmd does not affect hard tissue development or morphology in
the oral and craniofacial regions. We infer that functionally
redundant molecules may obscure the phenotype of Tnmd-KO
mice by compensating for Tnmd in the PDL. Previously, an
abnormal ultrastructure of collagen fibril, i.e., an increase in its
diameter, was observed in Tnmd-KO mice [23]. In the same study,
the authors found by IHC of type VI collagen alpha 3 (ColVIa3)
that the staining signal was diminished in Tnmd-KO mice, while it
was normally processed in the WT mice [23]. ColVI lies between
the cell surface and collagen bundle, providing an anchoring
network for cells to attach through surface receptors in various
interstitial tissues [30] and may indirectly regulate the collagen
fibrillogenesis [31,32]. Taken together, these results suggest that
Tnmd may enhance the cell adhesion of fibroblastic cells to Col
VI.
Recently, Qi J et al. proposed that Tnmd had three isoforms in
human tendon tissue [33], raising the possibility that isoform 1, 2,
and 3 fulfilled distinct intracellular functions similar to cytosine-
specific methyltransferase, SUMO protease, and a-syntriohin,
respectively. Given that Tnmd is a novel class of protein, it is
important to perform studies clarifying the isoforms as well as their
structures and functions. With regards to Tnmd isoform expression
in Tnmd-KO, the following data are known, which suggests that
isoforms are unlikely expressed in dense connective tissues in mice;
northern blot analysis detected no additional mRNA in WT or
Tnmd-KO mouse [11,12,23]; western blot analysis of WT or Tnmd-
KO mouse tissue samples detected no additional protein with
antibody against the C-terminal of Tnmd, which should be able to
detect isoform 1 and 3 [23]. It is possible that there are differences
between human and mouse and that species-specific isoforms exist.
However, information to conclude the mechanisms of Tnmd
function, including both the proposed isoform function and
enhancement of cell adhesion, is limited. Further comprehensive
studies on Tnmd-interacting proteins and its involvement in signal
transduction will further clarify mechanisms underlying diverse
biological functions of Tnmd, which may give us clues to
understand how dense connective tissue maturates. In addition,
validation on possible isoforms by northern blot analysis and
detection of the protein is necessary. Given the function of Tnmd
in cell adhesion and the ultrastructural phenotype of knockouts,
Tnmd may contribute to ECM remodeling by enhancing
fibroblast adhesion to ECM. Although the deletion of Tnmd does
not seem to largely affect the morphology of skeletal tissues, it is
possible that the elasticity and mechanical properties of the PDL
may be affected in Tnmd-KO mice. We may be able to observe
such phenotypes, if any, by directly measuring the mechanical
property of PDL or controlling the mechanical load to the teeth in
aged Tnmd-KO mice. As a model for measuring the mechanical
properties of PDL, a tension test might be the most suitable.
However, it is technically difficult to remove the tissue required for
the testing, due to the complexity of the murine molar
morphology. An alternative method for estimating the mechanical
properties of PDL would be an occlusal trauma model comparing
the periodontal damage between wild types and knockouts. We
may be able to observe such phenotypes, if any, by directly
measuring the mechanical property of PDL or controlling the
mechanical load to the teeth in aged Tnmd-KO mice.
The BRICHOS domain and CS region of Tnmd was re-
sponsible for Tnmd-mediated enhancement of cell adhesion,
indicating that the domain likely contains an effector for the
attachment of the cells. The BRICHOS domain has been
suggested to have several functions. These include targeting of
the secretory pathway, assistance to the specialized intracellular
protease processing system, and an intramolecular chaperone-like
function [14,17]. Although some of the members containing
a BRICHOS domain have been related to specific diseases, their
detailed roles have not been elucidated. Recently, Willander et al.
reported the high-resolution structure of the BRICHOS domain of
surfactant protein C and indicated that the domain had a protein
binding capacity [34]. Considering these results together, we infer
that Tnmd interacts with other proteins through the BRICHOS
domain to regulate cell adhesion. However, its counterpart and/or
whether it may directly or indirectly interact with the ECM are
still unclear. We previously showed that the CTD of the Tnmd
had an anti-angiogenic activity [10,20], which indicate that the
CTD could be a suppressor of cell-cell interaction or cell-matrix
adhesion for endothelial cells. Given that dense connective tissues
are hypovascularized, anti-angiogenic activity of the CTD and the
function of CS region and/or BRICHOS domain in cell adhesion
may cooperatively maintain the characteristics of the tissues
including tendons, ligaments, and the PDL.
In conclusion, Tnmd may be involved in cell adhesion, which
may be important to maintain collagen fibrils in the periodontal
ligament, when the tooth starts to function. Although the trigger of
Tnmd expression in the PDL and the detailed function in collagen
fibril formation are still unclear, our study shows the relation of
Tnmd expression to the time of PDL development. The Tnmd-
mediated enhancement of cell adhesion to ECM may be involved
in the formation and maintenance of the PDL as well as other
dense connective tissues. Further study would reveal the role of
Tnmd in dense connective tissue, which may enable us to control
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the remodeling of dense connective tissue and shed light on the
regeneration of the PDL.
Supporting Information
Figure S1 Establishment of anti-Tnmd antibody. (A)
Detection of Tnmd transfected in NIH3T3 cells. Human Tnmd
was transfected in NIH3T3 cells to evaluate antibody reactivity.
(B) Detection of FLAG-tagged Tnmd transfected in NIH3T3 cells
by western blot analysis. Cell lysates of transfected cells were first
detected using the anti-FLAG M2 antibody, then subsequently
with the anti-Tnmd antibody. (C) Immunohistological evaluation
of anti-Tnmd antibody. WT and Tnmd-KO mice tail specimens
were stained without the primary antibody, with normal rabbit
serum, or with anti-Tnmd antibody. Arrow indicates the region of
positive signal. c: cartilage, hf, hair follicle, m: muscle, n: nerve, t:
tendon. Scale bar = 500 mm.
(PDF)
Figure S2 Histological findings of Tnmd–KO mouse
teeth. H&E stainings of the maxilla first molar of 1, 2, 3, 4, and 6-
week-old WT or Tnmd-KO mice are shown. Scale bar = 500 mm.
Representative images are shown.
(PDF)
Figure S3 Micro CT analysis of craniofacial hard tissue
in 10-week-old WT and Tnmd-KO mice. (A) Sagittal plane
section image of WT and Tnmd-KO mice. Images are focused on
a maxillary incisor, mandibular incisor or molar. (B) Frontal plane
section image of WT and Tnmd-KO mice. Images are focused on
a first (M1), second (M2), or third molar (M3) and on the
temporomandibular joint (TMJ). (C) Horizontal plane section
image of WT and Tnmd-KO mice. Images are focused on the
plane, which intersects the molar root and external auditory canal.
mxi: maxillary incisor; mdi: mandibular incisor; mx: maxilla; md:
mandibule; tmj: temporomandibular joint; mxm: maxillary molar;
mdm: mandibularmolar; eac: external auditory canal.
(PDF)
Figure S4 Examination of glycosylation in Tnmd by
Tunicamycin treatment. Uncropped image of Figure 3B is
shown. Full length Tnmd or EGFP is transfected to NIH3T3 cells.
Tunicamycin was added 24 h after transfection, and cells were
harvested at 48 h after transfection. No protein was detected lower
than 37 kDa or higher than 50 kDa molecular weight.
(PDF)
Figure S5 Effect of Tnmd of Tnmd mutant transfection
on cell adhesion. Cell adhesion assay to Fibronectin are shown.
(A) Dose-dependent enhancement of cell adhesion by Tnmd.
FLAG-tagged Tnmd was transfected in combination with
pCAGGS-Venus in NIH3T3 cells. Cell adhesion to Fibronectin-
coated culture dishes was determined. (B) Cell adhesion of WT
and Tnmd-KO cells to Col I-coated culture dishes.
(PDF)
Figure S6 Subcellular localization of Tnmd in hPDL-
TERT cells. The subcellular localization of the Tnmd protein in
hPDL-TERT cells transfected with Tnmd was examined by ICC.
NIH3T3 cells transfected with Tnmd were double stained with cell
organelle markers and the anti-Tnmd . (A) Tnmd and plasma
membrane. (B) Tnmd and Golgi apparatus. (C) Tnmd and b-
Actin. (D) Tnmd and a-Tubulin. DAPI nuclear staining is shown
in blue, cell organelle markers in green, and anti-Tnmd antibody
in red. Scale bar = 50 mm.
(PDF)
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